Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis
about
Molecular functions of thyroid hormones and their clinical significance in liver-related diseasesSoluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicinFunctional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/beta-catenin signaling pathway in hepatocellular carcinoma cellsInactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinomaCoactivation of AKT and β-catenin in mice rapidly induces formation of lipogenic liver tumorsNovel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and developmentOverexpression of CTHRC1 in hepatocellular carcinoma promotes tumor invasion and predicts poor prognosisAberrant Promoter Methylation Profiles of Tumor Suppressor Genes in Hepatocellular Carcinomaβ-Catenin Signaling and Roles in Liver Homeostasis, Injury, and TumorigenesisMutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomasCharacteristic Analysis from Excessive to Deficient Syndromes in Hepatocarcinoma Underlying miRNA Array Data.Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC.Integrated Multiple "-omics" Data Reveal Subtypes of Hepatocellular Carcinoma.Hepatitis C-associated hepatocellular carcinomas in non-cirrhotic livers.Transcriptomic characterization of hepatocellular carcinoma with CTNNB1 mutation.Molecular genetics of hepatocellular neoplasia.Sixty-five gene-based risk score classifier predicts overall survival in hepatocellular carcinoma.Identification of drivers from cancer genome diversity in hepatocellular carcinoma.Role of Wnt/β-catenin signaling in liver metabolism and cancerUpregulation of the Wnt co-receptor LRP6 promotes hepatocarcinogenesis and enhances cell invasionbeta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance.Salinomycin inhibits proliferation and induces apoptosis of human hepatocellular carcinoma cells in vitro and in vivo.c-Myc and transforming growth factor α enhance the development of hepatic lesions due to mutant β-catenin in transgenic miceGenetic mechanisms of hepatocarcinogenesis.Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad.The prognostic molecular markers in hepatocellular carcinoma.A peculiar mutation spectrum emerging from young peruvian patients with hepatocellular carcinoma.Profiling of exome mutations associated with progression of HBV-related hepatocellular carcinoma.S100P expression is a novel prognostic factor in hepatocellular carcinoma and predicts survival in patients with high tumor stage or early recurrent tumors.Genetic alterations in hepatoblastoma and hepatocellular carcinoma: common and distinctive aspects.Molecular pathology of hepatic neoplasms: classification and clinical significance.Effect of mutant β-catenin on liver growth homeostasis and hepatocarcinogenesis in transgenic miceExpression of beta-catenin in hepatocellular carcinoma.Alpha-fetoprotein expression is a potential prognostic marker in hepatocellular carcinoma.Molecular mechanisms underlying hepatocellular carcinomaWnt signaling in liver cancer.Down-regulation of annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutationGenetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway.The Wnt/β-catenin signaling pathway in liver biology and disease.Molecular Determinants of Prognosis in Hepatocellular Carcinoma.
P2860
Q21284820-F21C2BF4-BD55-456E-BB4E-89143C3F4ABBQ24292953-582B4D3F-2DCF-4215-9934-8835EEBAC15BQ24320123-485874D6-5A6D-4E88-B6DA-B3D7A2AB750BQ24609544-9AFB5E4E-8D8D-4CEA-A0BB-F4065AE40DCFQ24620075-1A1C8967-CB6B-456B-BA7B-CDBB8D485B97Q26851211-267B3B22-6FA3-4212-BE34-2B9BE93209DFQ27310338-AF929C12-FBFB-4F9B-88B1-45D3E3AE805CQ27478395-A862A949-9F34-41E0-A35E-B30BE3D17052Q28087660-02A78870-FBC2-4BB6-89E7-006ABF906207Q28213290-766D1D86-058B-41A2-ABD0-5E903348A7BFQ30725051-FDD0B375-2FA3-456B-BF9B-17F67CB9F602Q30988387-B846E573-62D3-4830-A87A-7CE92A081107Q31140554-488F25FD-BB6D-4776-B04E-96CD778FEB89Q33516543-F3C8C5AB-CCFE-4D20-AC28-6A95FFF1AFECQ33567714-F7C95E00-80EB-40FD-8921-4E0FFEF130FEQ33680701-E7910497-345B-4AD5-95A9-740FE1C85190Q33766930-110827B2-B4D5-4F3A-B85A-AD4BFB2CE69DQ33907993-E0D055BD-BFEA-4975-A7ED-20A83AAEECE2Q33940403-01C3222F-8B59-4441-81DA-88C5D6D2F237Q34263359-CF250409-F005-4695-8A83-094A4AF7FAABQ34302259-2BEEA3C7-3C0F-4688-8D9D-0D581E9133C9Q34531550-CB0137EF-32D9-431F-BFEF-6DFAD946D547Q34539365-A257C975-0465-4567-87FE-23761EC132FCQ34611410-0B8C72DA-7A33-463E-BC51-4C7B00ACE8A8Q34630557-DFF01589-0AF7-476C-A838-70A6A17FBA86Q34668320-00C835A3-AFFB-4001-AB7F-B3D102E3E5DFQ34682006-FE76D87B-3E25-44D1-A329-867EDAFFBE4EQ34734133-B33AD7BB-9F2D-48C4-9382-7861C1B5F3E7Q34778723-5C8C7C8F-5510-420A-9623-AF9C7E48EC54Q34850055-5409E7A5-AAB5-4E50-9420-1BA85C20E8FEQ34954493-628DE848-B3E3-4AC0-9006-838D0E4979CFQ34978658-B9D6CD51-60CD-43DB-80B6-B412FB1FCB3DQ35010167-EABB06A4-9F57-42AB-98A6-7EA5BD4AB354Q35064510-F603245B-E4FE-40FD-99D5-5ABF5447875DQ35260040-72BFAEBB-86A8-460F-B4DD-1AB91B9AC224Q35659072-7898DEB5-FDFA-4662-A479-8D1427A789DCQ35748034-4D4E632C-AC18-4B77-97B8-A6346002044FQ35788845-958C4EEE-D1BC-4369-A326-151E68B5649AQ35819799-EFF20417-8376-4754-AC7A-D292D254D260Q35905975-BF4CF912-20DB-48FC-A148-F935482745B9
P2860
Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Beta-catenin mutations are ass ...... s and with favorable prognosis
@ast
Beta-catenin mutations are ass ...... s and with favorable prognosis
@en
Beta-catenin mutations are ass ...... s and with favorable prognosis
@nl
type
label
Beta-catenin mutations are ass ...... s and with favorable prognosis
@ast
Beta-catenin mutations are ass ...... s and with favorable prognosis
@en
Beta-catenin mutations are ass ...... s and with favorable prognosis
@nl
prefLabel
Beta-catenin mutations are ass ...... s and with favorable prognosis
@ast
Beta-catenin mutations are ass ...... s and with favorable prognosis
@en
Beta-catenin mutations are ass ...... s and with favorable prognosis
@nl
P2093
P2860
P3181
P1476
Beta-catenin mutations are ass ...... s and with favorable prognosis
@en
P2093
P2860
P304
P3181
P356
10.1016/S0002-9440(10)64590-7
P407
P577
2000-09-01T00:00:00Z